Incretin-based Drugs Market Overview 2026 and Forecast till 2035
The global incretin-based drugs market was valued at USD 38.69 billion in 2025 and is projected to exceed USD 72.63 billion by 2035. The market is expected to expand at a CAGR of more than 6.5% during the forecast period from 2026 to 2035. Rising prevalence of diabetes and obesity, increasing adoption of advanced glucose-lowering therapies, and continuous innovation in metabolic disease treatment are expected to drive long-term market growth.
Request Sample @ https://www.researchnester.com/sample-request-768
Incretin-based Drugs Industry Demand
